EP1996238
Tjáningarferjur adenóveira og dsRNA sem TLR3 gerandefni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.2.2007EP published:
6.4.2016EP application number:
07752109.4
EP translation filed:
10.6.2016Grant published:
15.7.2016EPO information:
European Patent Register
Max expiry date:
27.2.2027Expiry date:
27.2.2021
Title:
Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist
Timeline
Today
28.2.2007EP application
6.4.2016EP Publication
10.6.2016Translation submitted
15.7.2016Registration published
27.2.2021Expires
Owner
Name:
Vaxart, Inc.Address:
600 Townsend Street Suite 120E, 94103, San Francisco, CA, US
Inventor
Name:
TUCKER, Sean, N.Address:
San Francisco, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
778026 PDate:
28.2.2006Country:
US
Number:
801645 PDate:
19.5.2006Country:
US
Number:
802992 PDate:
22.5.2006Country:
US
Number:
821492 PDate:
4.8.2006Country:
US
Number:
846658 PDate:
22.9.2006Country:
US
Number:
848195 PDate:
28.9.2006Country:
US
Classification
Categories:
C07H 21/00, C07H 21/02, C07H 21/04, C12N 15/63, A61K 48/00, A61K 39/39
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 9.1.2017
Expires: 27.2.2018
Payer: Árnason Faktor
Number: 12
Paid: 26.1.2018
Expires: 27.2.2019
Payer: Árnason Faktor
Number: 13
Paid: 9.1.2019
Expires: 27.2.2020
Payer: Árnason Faktor
Number: 14
Paid: 14.1.2020
Expires: 27.2.2021
Payer: Árnason Faktor ehf.